The Bulgaria Financial Supervision Commission approved the prospectus for admission to trading on a regulated market of Bioiasys AD’s secured, non-convertible bond issue and entered the bonds in the register of public companies and other issuers of securities. The EUR 15,000,000 issue comprises 15,000 ordinary, dematerialized, registered, interest-bearing, freely transferable bonds with a nominal value of EUR 1,000 each. The floating coupon is set at six-month EURIBOR plus 1.00%, subject to a floor of 2.75% and a cap of 5.75% per annum, with interest payable every six months; the bonds have issue date 22.07.2025 and maturity date 22.07.2033 (ISIN BG2100021257).